Screener
D&A at other companies
Other financials
Where this comes from
Reported directly by LeMaitre Vascular in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The source filing: LeMaitre Vascular’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 6:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333762
FAQ
- What is LeMaitre Vascular's D&A?
- LeMaitre Vascular (LMAT) reported D&A of $2.66M in Q2 2026.
- How has LeMaitre Vascular's D&A changed year-over-year?
- LeMaitre Vascular's D&A increased by 0.5% year-over-year, from $2.65M to $2.66M.
- What is the long-term trend for LeMaitre Vascular's D&A?
- Over 3 years (2022 to 2025), LeMaitre Vascular's D&A has grown at a 3.4% compound annual growth rate (CAGR), from $9.43M to $10.42M.
- What does D&A mean?
- Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.
Ask your AI about LeMaitre Vascular's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude